Furthermore, a recent study carried out in colon cancer cell lines suggests that Kaiso is a methylation-dependent "opportunistic" oncogene, which represses the tumor suppressor gene CDKN2A and provides a survival advantage to colon cancer cells[7]. The gene discussed is CDKN2A; the disease is malignant colon neoplasm.